Exercise and Tumor Blood Flow in Breast Cancer Patients
NCT04416087 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-10-06
Summary
This research aims at investigating tumor blood flow response to acute exercise in human cancer patients. It is hypothesized and expected that acute exercise increases tumor blood flow, which could plausibly increase the efficacy of cancer treatment.
Conditions
- Cancer, Breast
Interventions
- OTHER
-
Exercise
Positron emission tomography (PET) imaging at rest and during supine bicycle exercise Tumor blood flow and its heterogeneity will be measured with PET at rest and during supine bicycle exercise.
Sponsors & Collaborators
-
Turku University Hospital
lead OTHER_GOV
Principal Investigators
-
Ilkka Heinonen, PhD · staff
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-07
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial
NCT04667481 ·Status: COMPLETED ·Phase: NA
-
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
NCT06190600 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063 ·Status: COMPLETED ·Phase: NA
-
High-Intensity Interval Training for Stage I-III Breast Cancer Patients
NCT02454777 ·Status: TERMINATED ·Phase: NA
-
Exercise for Ameliorating Chemotherapy Cardiotoxicity
NCT06595316 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects
NCT03131024 ·Status: COMPLETED ·Phase: NA
-
Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT03280836 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
NCT07023887 ·Status: RECRUITING
-
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00005800 ·Status: COMPLETED ·Phase: PHASE2
-
Energy Balance and Breast Cancer Aspects-II
NCT02240836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
NCT02087592 ·Status: COMPLETED ·Phase: NA
-
Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors
NCT07215364 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
NCT03429972 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer
NCT04367090 ·Status: COMPLETED ·Phase: PHASE1
-
Cardioprotective Effect of Acute Exercise in Breast Cancer Patients
NCT05467111 ·Status: RECRUITING ·Phase: NA
-
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
NCT02472353 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
NCT04352777 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
NCT00079118 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
NCT00461344 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery
NCT00015886 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00047099 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab
NCT06881940 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
NCT00944047 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
NCT00436566 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel
NCT00527449 ·Status: COMPLETED ·Phase: PHASE2